ip-001

Colon Cancer

Immunophotonics, Inc.Phase 1/2Active

CC

41/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 33/ 100
Competitive Position: 65/ 100

Competitive context

127 Active assets in the Colon Cancer cohort.

Asset / Sponsor	Phase	Rating
FLUOROURACILUM Akeso	Phase 4	BB
Eloxatin Sun Yat-sen University	Phase 3	BB
Calcium folinate pentahydrate Akeso	Phase 3	BB
Irinotecan SCRI Development Innovations, LLC	Phase 3	BB
MACROGOLS University Medical Center Ho Chi Minh City (UMC)	Phase 4	BB

View all 50 →

Same molecule, other indications

ip-001 is also rated in:

metastasis from malignant tumor of colonDormant

BB

Indicative ·

64 / 100

Colon Cancer Liver MetastasesDormant

B

Indicative ·

57 / 100

rectal cancerDormant

B

Indicative ·

57 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.